spacer
spacer

PDBsum entry 2wwh

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Transferase PDB id
2wwh

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
211 a.a. *
Ligands
T5A ×3
Metals
_NA ×5
Waters ×100
* Residue conservation analysis
PDB id:
2wwh
Name: Transferase
Title: Plasmodium falciparum thymidylate kinase in complex with ap5dt
Structure: Thymidilate kinase, putative. Chain: a, b, c. Engineered: yes
Source: Plasmodium falciparum. Organism_taxid: 36329. Strain: 3d7. Expressed in: escherichia coli. Expression_system_taxid: 469008.
Resolution:
2.70Å     R-factor:   0.191     R-free:   0.270
Authors: J.L.Whittingham,J.Carrero-Lerida,J.A.Brannigan,L.M.Ruiz-Perez, A.P.G.Silva,M.J.Fogg,A.J.Wilkinson,I.H.Gilbert,K.S.Wilson, D.Gonzalez-Pacanowska
Key ref: J.L.Whittingham et al. (2010). Structural basis for the efficient phosphorylation of AZT-MP (3'-azido-3'-deoxythymidine monophosphate) and dGMP by Plasmodium falciparum type I thymidylate kinase. Biochem J, 428, 499-509. PubMed id: 20353400
Date:
23-Oct-09     Release date:   21-Apr-10    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q8I4S1  (Q8I4S1_PLAF7) -  Thymidylate kinase from Plasmodium falciparum (isolate 3D7)
Seq:
Struc:
210 a.a.
211 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class 2: E.C.2.7.4.8  - guanylate kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: GMP + ATP = GDP + ADP
GMP
Bound ligand (Het Group name = T5A)
matches with 56.36% similarity
+ ATP
= GDP
+ ADP
   Enzyme class 3: E.C.2.7.4.9  - dTMP kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: dTMP + ATP = dTDP + ADP
dTMP
Bound ligand (Het Group name = T5A)
matches with 56.36% similarity
+ ATP
= dTDP
+ ADP
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
Biochem J 428:499-509 (2010)
PubMed id: 20353400  
 
 
Structural basis for the efficient phosphorylation of AZT-MP (3'-azido-3'-deoxythymidine monophosphate) and dGMP by Plasmodium falciparum type I thymidylate kinase.
J.L.Whittingham, J.Carrero-Lerida, J.A.Brannigan, L.M.Ruiz-Perez, A.P.Silva, M.J.Fogg, A.J.Wilkinson, I.H.Gilbert, K.S.Wilson, D.González-Pacanowska.
 
  ABSTRACT  
 
Plasmodium falciparum is the causative agent of malaria, a disease where new drug targets are required due to increasing resistance to current anti-malarials. TMPK (thymidylate kinase) is a good candidate as it is essential for the synthesis of dTTP, a critical precursor of DNA and has been much studied due to its role in prodrug activation and as a drug target. Type I TMPKs, such as the human enzyme, phosphorylate the substrate AZT (3'-azido-3'-deoxythymidine)-MP (monophosphate) inefficiently compared with type II TMPKs (e.g. Escherichia coli TMPK). In the present paper we report that eukaryotic PfTMPK (P. falciparum TMPK) presents sequence features of a type I enzyme yet the kinetic parameters for AZT-MP phosphorylation are similar to those of the highly efficient E. coli enzyme. Structural information shows that this is explained by a different juxtaposition of the P-loop and the azide of AZT-MP. Subsequent formation of the transition state requires no further movement of the PfTMPK P-loop, with no steric conflicts for the azide moiety, allowing efficient phosphate transfer. Likewise, we present results that confirm the ability of the enzyme to uniquely accept dGMP as a substrate and shed light on the basis for its wider substrate specificity. Information resulting from two ternary complexes (dTMP-ADP and AZT-MP-ADP) and a binary complex with the transition state analogue AP5dT [P1-(5'-adenosyl)-P5-(5'-thymidyl) pentaphosphate] all reveal significant differences with the human enzyme, notably in the lid region and in the P-loop which may be exploited in the rational design of Plasmodium-specific TMPK inhibitors with therapeutic potential.
 

 

spacer

spacer